Clinical Edge Journal Scan

Factors associated with depressive symptoms in PsA


 

Key clinical point: Depression is prevalent in patients with psoriatic arthritis (PsA), with patients not engaging in sports activities, experiencing fatigue, and having functional impairment being more likely to suffer from depression.

Major finding: Overall, 8.2% and 20.9% of patients with PsA had severe and moderate depressive symptoms, respectively. The odds of having depressive symptoms were higher in patients with functional impairment (odds ratio [OR] 1.08; P < .0001) and those experiencing fatigue (OR 1.56; P < .0001), whereas those engaging in sports for at least 1 hour/week were less likely to be depressed (OR 0.61; P = .0017).

Study details: This study included 1225 patients with PsA and 1245 patients with axial spondyloarthritis from the RABBIT-SpA cohort.

Disclosures: This study received open access funding from Projekt Deal, and RABBIT-SpA is supported by a joint, unconditional grant from AbbVie, Amgen, Biogen, and various other sources. The authors declared no conflicts of interest.

Source: Reich A et al. Depressive symptoms are associated with fatigue, poorer functional status and less engagement in sports in axSpA and PsA: An analysis from the RABBIT-SpA cohort. Arthritis Res Ther. 2023;25:136 (Aug 2). doi: 10.1186/s13075-023-03127-2.

Recommended Reading

Vitamin D deficiency linked to psoriasis severity
MDedge Rheumatology
Could risk stratifying methotrexate users lead to less frequent testing?
MDedge Rheumatology
Commentary: PsA domains and analysis of various biologics in PsA, August 2023
MDedge Rheumatology
What factors cause multiple biologic failure in psoriasis?
MDedge Rheumatology
Study validates use of new psoriatic arthritis prediction tool
MDedge Rheumatology
PsA biomarkers move researchers closer to predictive test
MDedge Rheumatology
DNA methylation markers may predict PsA development in patients with psoriasis
MDedge Rheumatology
Psoriasis affects well-being and clinical outcomes in juvenile PsA
MDedge Rheumatology
Structured weight loss intervention reduces serum IL-23 levels in obese patients with PsA
MDedge Rheumatology
Guselkumab modulates immune cell composition that may drive clinical response in PsA
MDedge Rheumatology